Clinical Update
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Capnography 101 Oxygenation and Ventilation
It’s Time to Start Using it! Capnography 101 Oxygenation and Ventilation What is the difference? Oxygenation and Ventilation Ventilation O Oxygenation (capnography) 2 (oximetry) CO Cellular 2 Metabolism Capnographic Waveform • Capnograph detects only CO2 from ventilation • No CO2 present during inspiration – Baseline is normally zero CD AB E Baseline Capnogram Phase I Dead Space Ventilation • Beginning of exhalation • No CO2 present • Air from trachea, posterior pharynx, mouth and nose – No gas exchange occurs there – Called “dead space” Capnogram Phase I Baseline A B I Baseline Beginning of exhalation Capnogram Phase II Ascending Phase • CO2 from the alveoli begins to reach the upper airway and mix with the dead space air – Causes a rapid rise in the amount of CO2 • CO2 now present and detected in exhaled air Alveoli Capnogram Phase II Ascending Phase C Ascending II Phase Early A B Exhalation CO2 present and increasing in exhaled air Capnogram Phase III Alveolar Plateau • CO2 rich alveolar gas now constitutes the majority of the exhaled air • Uniform concentration of CO2 from alveoli to nose/mouth Capnogram Phase III Alveolar Plateau Alveolar Plateau CD III AB CO2 exhalation wave plateaus Capnogram Phase III End-Tidal • End of exhalation contains the highest concentration of CO2 – The “end-tidal CO2” – The number seen on your monitor • Normal EtCO2 is 35-45mmHg Capnogram Phase III End-Tidal End-tidal C D AB End of the the wave of exhalation Capnogram Phase IV Descending Phase • Inhalation begins • Oxygen fills airway • CO2 level quickly -
Board of Directors Chosen Valley Care Center & Apartments
Views From The Valley Fall and Winter, 2019 2019 Walk N Roll Charlie and his granddaughter Page 2 Board of Directors Chosen Valley Care Center & Apartments Mary Patten Mike Thieke Dan Hollermann Amy Vreeman Gary Bren Pam Holte Angie Bicknese Sheryl Bennett Mary L. Allen Maureen Ruskell Views from the Valley Contributing Writers: Craig Backen, Administrator [email protected] Lisa Vickerman, Director of Clinical & Resident Services [email protected] Ellen Strande, Director of Human Resources [email protected] Carrie Colbenson, Director of Nursing [email protected] Melissa Fenske, Director of Social Services [email protected] Gerry Gathje, Director of Environmental Services [email protected] Kate Glor, Director of the Dept. of Life Enrichment [email protected] Jody Lawstuen, Environmental Services Supervisor [email protected] Barb Weiss, Director of Food and Nutrition Services [email protected] Erin Amdahl, Business Office Manager [email protected] Robert (Bob) Schrupp, Physical Therapist [email protected] Spotlight Writer: Mimi Seamens, MRP Page 3 From The Administrator’s Desk Hi Everyone, We are just weeks away from the Care Center building addition and renovation project. Project planning has been very successful, and we will soon be breaking ground! The project is scheduled to begin in October and be completed in October 2021. The project will begin with an addition between the end of E Wing and D Wing. Next, a new therapy addition and private rooms (suites) on A Wing will be completed. Then, renovations will occur throughout D Wing and E Wing. As noted in my previous article, there are numerous project priorities for what we want to accomplish in the Care Center. -
Annex 2. List of Procedure Case Rates (Revision 2.0)
ANNEX 2. LIST OF PROCEDURE CASE RATES (REVISION 2.0) FIRST CASE RATE RVS CODE DESCRIPTION Health Care Case Rate Professional Fee Institution Fee Integumentary System Skin, Subcutaneous and Accessory Structures Incision and Drainage Incision and drainage of abscess (e.g., carbuncle, suppurative hidradenitis, 10060 3,640 840 2,800 cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia) 10080 Incision and drainage of pilonidal cyst 3,640 840 2,800 10120 Incision and removal of foreign body, subcutaneous tissues 3,640 840 2,800 10140 Incision and drainage of hematoma, seroma, or fluid collection 3,640 840 2,800 10160 Puncture aspiration of abscess, hematoma, bulla, or cyst 3,640 840 2,800 10180 Incision and drainage, complex, postoperative wound infection 5,560 1,260 4,300 Excision - Debridement 11000 Debridement of extensive eczematous or infected skin 10,540 5,040 5,500 Debridement including removal of foreign material associated w/ open 11010 10,540 5,040 5,500 fracture(s) and/or dislocation(s); skin and subcutaneous tissues Debridement including removal of foreign material associated w/ open 11011 fracture(s) and/or dislocation(s); skin, subcutaneous tissue, muscle fascia, 11,980 5,880 6,100 and muscle Debridement including removal of foreign material associated w/ open 11012 fracture(s) and/or dislocation(s); skin, subcutaneous tissue, muscle fascia, 12,120 6,720 5,400 muscle, and bone 11040 Debridement; skin, partial thickness 3,640 840 2,800 11041 Debridement; skin, full thickness 3,640 840 2,800 11042 Debridement; skin, and -
Trinity Ems System Skills Procedures
Procedures 12 Lead EKG Procedure 01 Cardioversion Procedure 28 Airway: BPAP Procedure 02 Chest Decompression Needle Procedure 29 Airway: CPAP Procedure 03 Chest Tube Maintenance Procedure 30 Airway: End-Tidal CO2 Procedure 04 Childbirth Procedure 31 Airway: ETT Introducer (Bougie) Procedure 05 Decontamination Procedure 32 Airway: Foreign Body Obstruction Procedure 06 Airway: Intubation Nasotracheal Procedure 07 Defibrillation: Automated Airway: Intubation Orotracheal Procedure 08 External Defibrillator (AED) Procedure 33 Defibrillation: Manual Procedure 34 Airway: King LTD Procedure 09 Airway: Nebulizer Inhalation EKG Monitoring Procedure 35 Therapy Procedure 10 Impedance Threshold Device (ITD) Procedure 36 Airway: Rapid Sequence Intubation Procedure 11 Injections: Subcutaneous Airway: Respirator Operation Procedure 12 and intramuscular Procedure 37 Airway: Suctioning – Advanced Procedure 13 Intranasal Medication Airway: Suctioning – Basic Procedure 14 Airway: Surgical Cricothyrotomy Procedure 15 Administration Procedure 38 Airway: Tracheostomy Tube Change Procedure 16 Pulse Oximetry Procedure 39 Airway: Ventilator Operation Procedure 17 Restraints: Physical/Chemical Procedure 40 Arterial Line Maintenance Procedure 18 Spinal Examination Procedure 41 Assessment: Adult Procedure 19 Spinal Immobilization Procedure 42 Assessment: Pain Procedure 20 Splinting Procedure 43 Assessment Pediatric Procedure 21 Stroke Screen: (Cincinnati Blood Glucose Analysis Procedure 22 Pre-hospital) Procedure 44 Capnography Procedure 23 Cardiac: External Pacing -
Respiratory Therapy Pocket Reference
Pulmonary Physiology Volume Control Pressure Control Pressure Support Respiratory Therapy “AC” Assist Control; AC-VC, ~CMV (controlled mandatory Measure of static lung compliance. If in AC-VC, perform a.k.a. a.k.a. AC-PC; Assist Control Pressure Control; ~CMV-PC a.k.a PS (~BiPAP). Spontaneous: Pressure-present inspiratory pause (when there is no flow, there is no effect ventilation = all modes with RR and fixed Ti) PPlateau of Resistance; Pplat@Palv); or set Pause Time ~0.5s; RR, Pinsp, PEEP, FiO2, Flow Trigger, rise time, I:E (set Pocket Reference RR, Vt, PEEP, FiO2, Flow Trigger, Flow pattern, I:E (either Settings Pinsp, PEEP, FiO2, Flow Trigger, Rise time Target: < 30, Optimal: ~ 25 Settings directly or by inspiratory time Ti) Settings directly or via peak flow, Ti settings) Decreasing Ramp (potentially more physiologic) PIP: Total inspiratory work by vent; Reflects resistance & - Decreasing Ramp (potentially more physiologic) Card design by Respiratory care providers from: Square wave/constant vs Decreasing Ramp (potentially Flow Determined by: 1) PS level, 2) R, Rise Time ( rise time ® PPeak inspiratory compliance; Normal ~20 cmH20 (@8cc/kg and adult ETT); - Peak Flow determined by 1) Pinsp level, 2) R, 3)Ti (shorter Flow more physiologic) ¯ peak flow and 3.) pt effort Resp failure 30-40 (low VT use); Concern if >40. Flow = more flow), 4) pressure rise time (¯ Rise Time ® Peak v 0.9 Flow), 5) pt effort ( effort ® peak flow) Pplat-PEEP: tidal stress (lung injury & mortality risk). Target Determined by set RR, Vt, & Flow Pattern (i.e. for any set I:E Determined by patient effort & flow termination (“Esens” – PDriving peak flow, Square (¯ Ti) & Ramp ( Ti); Normal Ti: 1-1.5s; see below “Breath Termination”) < 15 cmH2O. -
Capnography - Microstream® Etco2
Capnography - Microstream® EtCO2 10 11 12 6 | Patient Monitoring catalog 2016 Capnography - Microstream® EtCO2 Microstream® EtCO2 Solution Single Patient Use Product # Description Packaging Use with:* M1920A FilterLine Set, Adult/Pedi, Intubated M1921A FilterLine H Set, Adult/Pedi, Intubated M1923A FilterLine H Set, Infant/Neonatal, Intubated 989803160241 FilterLine® Set Long, Adult/Pediatric 25 sets 989803160251 FilterLine H Set Long, Adult/Pediatric Microstream® Ext: M3015A, M3015B, MP5: M8105A, 989803160261 FilterLine H Set Long, Infant/Neonatal M8105AS, VM8: 863066, VM1: 863266 989803159571 VitaLine™ H Set, Adult/Pediatric Efficia CM10 (863301), CM12 (863303), CM100 (863300), CM120 (863302), CM150 (863304) 989803159581 VitaLine™ H Set, Infant/Neonatal M2520A Smart CapnoLine® O2 Pediatric M2522A Smart CapnoLine® O2 Adult/Intermediate 25 FilterLines® 11 M2524A Smart CapnoLine® Pediatric M2526A Smart CapnoLine® Adult/Intermediate * Please reference the MySupplies or the e-store website for more details on hardware compatibility. Patient Monitoring catalog 2016 | 7 Capnography - Microstream® EtCO2 13 14 15 16 17 18 19 8 | Patient Monitoring catalog 2016 Capnography - Microstream® EtCO2 Microstream® EtCO2 Solution Single Patient Use (continued) Product # Description Reusable/ Single Patient Use Packaging Use with:* 13 989803160271 Smart CapnoLine® O2 Pediatric Long 989803160281 Smart CapnoLine® O2 Plus Adult Long 989803160301 Smart CapnoLine® Plus Adult Long 14 M4680A CapnoLine® H O2 Adult 15 M4681A CapnoLine® H O2 Pediatric 16 M4686A NIV -
Conversion of Emergent Cricothyrotomy to Tracheotomy in Trauma Patients
REVIEW ARTICLE Conversion of Emergent Cricothyrotomy to Tracheotomy in Trauma Patients Peep Talving, MD, PhD; Joseph DuBose, MD; Kenji Inaba, MD; Demetrios Demetriades, MD, PhD Objectives: To review the literature to determine the patients for whom cricothyrotomy was performed, in- rates of airway stenosis after cricothyrotomy, particu- cluding 368 trauma patients who underwent emergent larly as they compare with previously documented rates cricothyrotomy. The rate of chronic subglottic stenosis of this complication after tracheotomy, and to examine among survivors after cricothyrotomy was 2.2% (11/ the complications associated with conversion. 511) overall and 1.1% (4/368) among trauma patients for follow-up periods with a range from 2 to 60 months. Only Data Sources: We conducted a review of the medical 1 (0.27%) of the 368 trauma patients in whom an emer- literature by the use of PubMed and OVID MEDLINE da- gent cricothyrotomy was performed required surgical tabases. treatment for chronic subglottic stenosis. Although the literature that documents complications of surgical air- Study Selection: We identified all published series that way conversion is scarce, rates of severe complications describe the use of cricothyrotomy, with the inclusion of up to 43% were reported. of the subset of patients who require an emergency air- way after trauma, from January 1, 1978, to January 1, Conclusions: Cricothyrotomy after trauma is safe for ini- 2008. tial airway access among patients who require the estab- lishment of an emergent airway. The prolonged use of a Data Extraction: Only 20 published series of crico- cricothyrotomy tube, however, remains controversial. Al- thyrotomy were identified: 17 retrospective reports and though no study to date has demonstrated any benefit 3 prospective, observational series. -
Evaluation and Endoscopic Management of Persistent Air Leaks
Review Article Page 1 of 13 Evaluation and endoscopic management of persistent air leaks Virgil Secasanu1, Sevak Keshishyan2, Alberto E. Revelo1 1Division of Pulmonary, Critical Care, and Sleep Medicine, Interventional Pulmonology Section, The Ohio State University Wexner Medical Center Columbus, OH, USA; 2Division of Pulmonary, Critical Care and Sleep Medicine, Beebe Medical Center, Lewes, DE, USA Contributions: (I) Conception and design: AE Revelo; (II) Administrative support: none; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretations: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Alberto E. Revelo, MD. Assistant Professor of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Interventional Pulmonology Section, The Ohio State University Wexner Medical Center Columbus, Davis Heart & Lung Research Institute, 473 West 12thAvenue, Columbus, OH 43210, USA. Email: [email protected]. Abstract: The endoscopic management of persistent or prolonged air leak (PAL) has gained popularity, not only in post-surgical PAL but also in non-surgical scenarios. The literature that supports an endoscopic approach is restricted to case series, case reports, retrospective and some small prospective studies. Every patient who suffers from PAL secondary to bronchopleural fistula (BPF) or alveolopleural fistula (APF) should always be evaluated to determine surgical repair candidacy. There have been a number of articles that summarize the bronchoscopic modalities for the management of PAL, but none emphasize the initial evaluation with an algorithmic approach or discuss how to follow-up these patients in the immediate post- treatment phase and long-term. -
Surgical Management of Laryngotracheal Stenosis in Adults
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Serveur académique lausannois Eur Arch Otorhinolaryngol (2005) 262: 609–615 DOI 10.1007/s00405-004-0887-9 LARYNGOLOGY Mercy George Æ Florian Lang Æ Philippe Pasche Philippe Monnier Surgical management of laryngotracheal stenosis in adults Received: 22 July 2004 / Accepted: 18 October 2004 / Published online: 25 January 2005 Ó Springer-Verlag 2005 Abstract The purpose was to evaluate the outcome fol- the efficacy and reliability of this approach towards the lowing the surgical management of a consecutive series management of laryngotracheal stenosis of varied eti- of 26 adult patients with laryngotracheal stenosis of ologies. Similar to data in the literature, post-intubation varied etiologies in a tertiary care center. Of the 83 pa- injury was the leading cause of stenosis in our series. A tients who underwent surgery for laryngotracheal ste- resection length of up to 6 cm with laryngeal release nosis in the Department of Otorhinolaryngology and procedures (when necessary) was found to be technically Head and Neck Surgery, University Hospital of Lau- feasible. sanne, Switzerland, between 1995 and 2003, 26 patients were adults (‡16 years) and formed the group that was Keywords Laryngotracheal stenosis Æ Laryngotracheal the focus of this study. The stenosis involved the trachea resection Æ Anastomosis (20), subglottis (1), subglottis and trachea (2), glottis and subglottis (1) and glottis, subglottis and trachea (2). The etiology of the stenosis was post-intubation injury (n =20), infiltration of the trachea by thyroid tumor (n Introduction =3), seeding from a laryngeal tumor at the site of the tracheostoma (n =1), idiopathic progressive subglottic In the majority of patients, acquired stenosis of the sub- stenosis (n =1) and external laryngeal trauma (n =1). -
April 2009 429 Association News
President’s Page Dear Colleagues and Friends; Some of you may wonder whether or not AsMA has any impact on the Aeromedical community as a whole; whether there is anything more to our organiza- tion than our annual meeting, networking, and our monthly journal. I can tell you that due to the efforts of so many of you who serve on committees, working groups, and in a host of leadership roles, AsMA contin- ues to be recognized as the voice of international aero- space medicine. Here are but a few examples. There are a number of programs and 'tools’ that are employed by the airlines and military that are de- signed to proactively identify and control those behav- Andrew H. Bellenkes, Ph.D. iors that have the potential to contribute to or directly cause mishaps. Several of these programs involve the released a point paper concerning medical standards as- voluntary and anonymous reporting by aircrews and sociated with civilian passengers who will be on board ground personnel of such behaviors via various means. commercial sub-orbital flights. As a follow-up to this ef- This type of reporting is founded on the principle of fort, AsMA Home Office has been working with both non-attribution and is theoretically non-punitive. One of our Space Medicine Association (Ms. Genie Bopp, these, the Aviation Safety Action Program (ASAP), has President) and Society of NASA Flight Surgeons (Dr. J. been used by airlines for some time. It recently came to Michael Duncan, President) as well as an an Ad Hoc AsMA’s attention, however, that several airlines had group to help define aeromedical standards for the opted to terminate the use of ASAP in the course of their crews of these flights. -
Capnometry and Anaesthesia
617 Review Article Capnometry K. Bhavani-Shankar roD, H. Moseley FFARCS, A.Y. Kumar too, Y. Delph DA and anaesthesia In the last decade, capnography has developed from a research siste doit comprendre les principes de fonctionnement de cette instrument into a monitoring device considered to be essential technique. La prdsente r~vision d~crit les m~thodes disponibles during anaesthesia to ensure patient safety. Hence, a compre- de mesure de gaz carbonique (C02) expirL ainsi qu 'une analyse hensive understanding of capnography has become mandatory de la physiologie associ~e aux diffdrents capnogrammes. Une for the anaesthetist in charge of patients in the operating room description des applications cliniques de la capnographie fait and in the intensive care unit. This review of capnography suite it ces ~nonc~s thdoriques. Les effets de la pression baromd- includes the methods available to determine carbon dioxide in trique, de la vapeur d'eau, du protoxide d 'azote et de plusieurs expired air, and an analysis of the physiology of capnograms, autres facteurs affectant la mesure du CO 2 it l 'aide d'infra-rouge which are followed by a description of the applications of sont d~crits. La capnographie permet une mesure indirecte de la capnography in clinical practice. The theoretical backgrounds circulation pulmonaire, de la production de CO 2 et de la of the effect of barometric pressure, water vapour, nitrous oxide ventilation alv~olaire. Ces mesures sont influenc~es par de and other factors introducing errors in the accuracy of CO 2 nombreux facteurs physiologiques qu 'il importe de bien con- determination by the infra-red technique, currently the most nattre afin de ddterminer les limites de ce monitorage. -
Monitoring© Jones & Bartlett Learning, LLC NOT for SALE OR DISTRIBUTION NOT for SALE OR DISTRIBUTION CONTENTS
© Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION CHAPTER 3 © Jones & Bartlett Learning, LLC Monitoring© Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION CONTENTS ■■ Intraoperative Monitoring Standards ■■ EKG © Jones & Bartlett■■ Cuff Blood Learning, Pressure LLC © Jones & Bartlett Learning, LLC NOT FOR SALE■■ Arterial OR LineDISTRIBUTION NOT FOR SALE OR DISTRIBUTION ■■ Central Venous Catheter (CVP) or CV Catheter (CVC) ■■ Pulmonary Artery Catheterization (PAC) Monitors or PA Pressure (PAP) © Jones & Bartlett Learning,■■ Mixed LLC Venous Oxygen Saturation © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION(SvO2 or MvO2) NOT FOR SALE OR DISTRIBUTION ■■ Transesophageal Echocardiograph (TEE) ■■ Leveling Transducer and Calibrating Invasive Lines ■■ Pulse Oximetry ■■ Capnography and ETCO2 © Jones & Bartlett Learning, LLC ■■ Neuromuscular Blockade© Jones Monitoring & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION ■■ Neurologic: EEG andNOT BIS FOR SALE OR DISTRIBUTION ■■ Neurophysiology Monitoring ■■ Temperature Monitoring © Jones & Bartlett Learning, LLC 83 © Jones & Bartlett Learning, LLC NOT FOR SALE© Jones OR & Bartlett DISTRIBUTION Learning, LLC. NOT FOR SALE OR DISTRIBUTION